Christopher Jones, M.D., F.A.C.R., Radiation Oncologist, Sutter Health Medical Group

California Pacific CURRENTS: The online journal of CPMC Research Institute

Leading advances in new radiotherapy techniques to treat cancer; optimizing imaging technologies to predict tumor recurrence and visualize response to therapy

Research Overview

  • Dr. Christopher Jones is a board-certified radiation oncologist who specializes in the use of ionizing radiation to treat cancer, focusing on tumors of the head and neck, prostate, and brain.
  • He investigates optimal use of radiation therapy (radiotherapy) techniques including intensity modulated radiation therapy (IMRT), high-dose brachytherapy, and image-guided radiation therapy.
  • Dr. Jones is a Principal Investigator for Radiation Therapy Oncology Group (RTOG) National Cancer Institute-sponsored oncology group clinical trials.
  • He has authored numerous publications and abstracts on radiotherapy and imaging techniques to assess cancer progression, predict tumor recurrence after surgery and radiotherapy, and visualize response to treatment.
  • Dr. Jones lectures nationally and internationally on the role of radiation therapy in the management of head and neck cancers.

Read more about research among the Sutter Cancer Research Consortium.

Find additional information on oncology research and clinical trials at the Sutter Institute for Medical Research.


Training

Dr. Jones received his M.D. from Rush University in Chicago. He completed residency training in radiation oncology at Massachusetts General Hospital and Harvard Medical School in Boston.


 

Publication Search

Publications

Jacob V, Chattopadhyay SK, Proia KK, Hopkins DP, Reynolds J, Thota AB, Jones CD, Lackland DT, Rask KJ, Pronk NP, Clymer JM, Goetzel RZ, Community Preventive Services Task Force., Economics of Self-Measured Blood Pressure Monitoring: A Community Guide Systematic Review. Am J Prev Med

Lee R, Nayernama A, Jones SC, Wroblewski T, Waldron PE, Ibrutinib-associated Pneumocystis jirovecii pneumonia. Am J Hematol

Roach M, Yan Y, Lawton CA, Hsu IJ, Lustig RA, Jones CU, Rotman M, Zeitzer KL, Werner-Wasik M, Kim H, Thomas CR, Shipley WU, Sandler HM, Radiation Therapy Oncology Group (RTOG) 9413: Randomized trial comparing whole pelvic radiotherapy (WPRT) to prostate only (PORT) and neoadjuvant hormone therapy (NHT) to adjuvant hormone therapy (AHT). J Clin Oncol

Efstathiou JA, Paulus R, Smith MR, Jones CU, Leibenhaut MH, Husain SM, Rotman M, Souhami L, Sandler HM, Shipley WU, Cardiovascular mortality following short-term androgen deprivation in clinically localized prostate cancer: An analysis of RTOG 94-08. J Clin Oncol

Slusser K, Power S, Jones CA, LeBlanc TW, Kamal A, Desai D, Allen D, Galanos AN, Early palliative care on an inpatient oncology unit: Impact of a novel co-rounding partnership on patient and health system outcomes. J Clin Oncol

VIEW ALL
Christopher Jones, M.D., F.A.C.R., Radiation Oncologist, Sutter Health Medical Group
Primary Research Interests
  • Radiotherapy
  • Radiosurgery
  • Cancers of the head and neck, prostate and brain (gliomas)